Status:
COMPLETED
Oral Anti-coagulants in Fragile Patients With Percutaneous Endoscopic Gastrostomy and Atrial Fibrillation (ORIGAMI) Pilot Study
Lead Sponsor:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18+ years
Brief Summary
Compelling evidences support the safety of direct oral anticoagulants (DOAC) compared to Vitamin K antagonists (VKA) in patients with non-valvular atrial fibrillation. The 2018 EHRA/ESC practical guid...
Detailed Description
Several studies support the safety of direct oral anticoagulants (DOAC) compared to Vitamin K antagonists (VKA) in patients with non-valvular atrial fibrillation. The 2018 EHRA/ESC practical guide on...
Eligibility Criteria
Inclusion
- Patients with PEG and indication for treatment with long-term oral anticoagulant therapy
- Patients with Atrial Fibrillation
Exclusion
- Children under 18 years old.
- Life expectancy \<30 days.
- Lack of informed consent.
Key Trial Info
Start Date :
April 7 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 10 2021
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT04271293
Start Date
April 7 2020
End Date
August 10 2021
Last Update
November 1 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Rome, Italy, 00168